U.S. markets close in 3 hours 12 minutes
  • S&P 500

    4,180.12
    -41.74 (-0.99%)
     
  • Dow 30

    33,373.32
    -450.13 (-1.33%)
     
  • Nasdaq

    14,063.50
    -97.85 (-0.69%)
     
  • Russell 2000

    2,258.26
    -29.20 (-1.28%)
     
  • Crude Oil

    71.62
    +0.58 (+0.82%)
     
  • Gold

    1,774.30
    -0.50 (-0.03%)
     
  • Silver

    26.00
    +0.15 (+0.58%)
     
  • EUR/USD

    1.1879
    -0.0031 (-0.26%)
     
  • 10-Yr Bond

    1.4600
    -0.0510 (-3.38%)
     
  • GBP/USD

    1.3817
    -0.0107 (-0.77%)
     
  • USD/JPY

    110.2460
    +0.0150 (+0.01%)
     
  • BTC-USD

    36,618.54
    -1,800.34 (-4.69%)
     
  • CMC Crypto 200

    906.11
    -33.83 (-3.60%)
     
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • Nikkei 225

    28,964.08
    -54.25 (-0.19%)
     

Tilray Shares Plunge On The Heels Of $90.4M Equity Offering

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Tilray Inc. (NASDAQ: TLRY) announced Friday that it has priced a $90.4-million equity offering.

The Nanaimo, Canada-based company is offering 7.25 million Class 2 shares and, in place of Class 2 shares, pre-funded warrants to buy 11.75 million Class 2 shares and accompanying warrants to buy 19 million Class 2 shares at a price of $4.76 per share.

Tilray said it plans to utilize the net proceeds from the offering for corporate purposes.

The warrants have a five-year term from the date of exercisability, which should be around six months upon issuance at a price of $5.95 per share of Class 2 shares, according to Tilray.

The offering is expected to be finalized March 17, the company said. 

Canaccord Genuity LLC is the sole book-running manager for the offering.

The stock was down 32.77% at $4 at the time of publication Friday. 

Related Links:

Why Restructurng Efforts Don't Necessarily Signal The End Of A Cannabis Company's Downturn

The Week In Cannabis: Coronavirus Concerns, Moves In UK And Mexico, Tilray Earnings, Canopy Growth Cuts

Photo courtesy of Tilray. 

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.